BYSI BeyondSpring, Inc. - Ordinary Shares
$0.72
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026
52W Range
$1–$2
3% of range
Analyst Rating
STRONG BUY
7 analysts
Price Target
—
P/E (TTM)
—
ROE
3.1%
Net Profit Margin
—
BYSI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.72
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$0
Div Yield
—
ROE
3.1%
Debt/Equity
—
52W Range
$1 – $2
BYSI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$0
2023-12-31
→
2025-12-31
EPS
—
Free Cash Flow
$-20M
2024-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BYSI
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BYSI
Peer Median
ROA
-3.3%
-78.1%
ROE
3.1%
-228.7%
ROIC
28.1%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BYSI
Peer Median
Current Ratio
1.5
1.2
Quick Ratio
0.9
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BYSI
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BYSI
Peer Median
BYSI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 3 42.9%
- Buy 3 42.9%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.03%
Next Report
Sep 04, 2026
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.05 | — | — |
| Dec. 31, 2021 | $-0.24 | $-0.27 | 0.03% |
| Sept. 30, 2021 | $-0.47 | $-0.38 | -0.09% |
| June 30, 2021 | $-0.49 | $-0.33 | -0.16% |
| March 31, 2021 | $-0.44 | $-0.55 | 0.11% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BYSI | — | — | — | — | 3.1% | — |
| LTRN | — | -1.9 | — | — | — | — |
| LITS | $16M | -1.0 | 33.8% | — | -81.7% | — |
| GRML | — | — | — | — | -104.9% | — |
| GRDX | $20M | -1.1 | — | -17634.4% | -68.6% | -1813.6% |
| DYAI | — | -4.1 | -11.6% | — | — | — |
| ATOS | $5M | -0.1 | — | — | -71.7% | — |
| KYNB | $36M | 0.2 | -78.3% | 2848.6% | -143.5% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 10
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | |
| R&D Expense | $4M | $3M | $7M | |
| SG&A Expense | $5M | $6M | $8M | |
| Operating Income | $-9M | $-9M | $-15M | |
| Interest Income | $78.0K | $59.0K | $322.0K | |
| Pretax Income | $-9M | $-9M | $-14M | |
| Income Tax | $90.0K | $96.0K | $-92.0K | |
| Net Income | $-1M | $-11M | $-21M | |
| EPS (Basic) | $-0.02 | $-0.28 | $-0.54 | |
| EBITDA | $-9M | $-9M | · |
Balance Sheet 22
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | $5M | |
| Short-term Investments | $5M | $0 | · | |
| Prepaid Expense | $71.0K | $68.0K | $168.0K | |
| Current Assets | $21M | $29M | $18M | |
| PP&E (Net) | $166.0K | $239.0K | $317.0K | |
| PP&E (Gross) | $807.0K | $793.0K | $799.0K | |
| Accum. Depreciation | $641.0K | $554.0K | $482.0K | |
| Other Non-current Assets | $224.0K | $213.0K | $123.0K | |
| Total Assets | $26M | $34M | $25M | |
| Accounts Payable | $363.0K | $295.0K | $561.0K | |
| Accrued Liabilities | $938.0K | $840.0K | $2M | |
| Current Liabilities | $14M | $11M | $8M | |
| Capital Leases | $0 | $307.0K | $589.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | |
| Total Liabilities | $50M | $49M | $48M | |
| Common Stock | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $376M | $373M | $369M | |
| Retained Earnings | $-408M | $-407M | $-396M | |
| AOCI | $602.0K | $1M | $894.0K | |
| Stockholders' Equity | $-32M | $-33M | $-27M | |
| Liabilities + Equity | $26M | $34M | $25M | |
| Shares Outstanding | 41,122,320 | 40,316,320 | 39,029,163 |
Cash Flow 11
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $722.0K | $2M | $770.0K | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-20M | $-16M | $-16M | |
| CapEx | $50.0K | $224.0K | $100.0K | |
| Investing Cash Flow | $11M | $-12M | $-100.0K | |
| Stock Issued | $2M | $3M | $0 | |
| Net Stock Activity | $2M | $3M | · | |
| Financing Cash Flow | $5M | $27M | $4.0K | |
| Net Change in Cash | $-4M | $-2M | $-17M | |
| Taxes Paid | $2.0K | $7.0K | $36.0K | |
| Free Cash Flow | $-20M | $-17M | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -3.3% | -37.6% | · | |
| ROE | 3.1% | 37.3% | · | |
| ROIC | 28.1% | 26.3% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 1.5 | 2.6 | · | |
| Quick Ratio | 0.9 | 0.3 | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Valuation (TTM) 6
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | |
| Net Income TTM | $-1M | $-11M | · | |
| Market Cap | · | $66M | · | |
| P/B | · | -2.0 | · | |
| P / Cash Flow | · | -4.0 | · | |
| P / FCF | · | -3.9 | · |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $973.0K | $1M | $1M | $1M | $1M | $874.0K | $472.0K | $622.0K | |
| SG&A Expense | $758.0K | $1M | $1M | $751.0K | $947.0K | $2M | $1M | $2M | |
| Operating Income | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | |
| Interest Income | $4.0K | $8.0K | $14.0K | $19.0K | $28.0K | $17.0K | $4.0K | $15.0K | |
| Pretax Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | |
| Income Tax | $100.0K | $192.0K | $22.0K | $26.0K | $22.0K | $20.0K | $96.0K | $0 | |
| Net Income | $-849.0K | $-2M | $-2M | $-2M | $-2M | $4M | $-2M | $-2M | |
| EPS (Basic) | $-0.02 | $-0.05 | $-0.05 | $-0.04 | $-0.04 | $0.11 | $-0.05 | $-0.05 | |
| EPS (Diluted) | · | · | · | $0.16 | $-0.10 | · | · | · | |
| Shares (Basic) | 41,119,820 | 41,119,803 | · | 40,317,266 | 40,316,320 | 40,316,320 | · | 40,300,350 | |
| EBITDA | $-2M | $-2M | · | $-2M | $-2M | $-3M | · | · |
Balance Sheet 22
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $8M | $12M | $10M | $7M | $3M | · | |
| Short-term Investments | $4M | $4M | $5M | $141.0K | · | $2M | $0 | · | |
| Prepaid Expense | $273.0K | $181.0K | $71.0K | $131.0K | $200.0K | $90.0K | $68.0K | · | |
| Current Assets | $10M | $14M | $21M | $24M | $26M | $32M | $29M | · | |
| PP&E (Net) | $138.0K | $152.0K | $166.0K | $184.0K | $202.0K | $221.0K | $239.0K | · | |
| PP&E (Gross) | $817.0K | $812.0K | $807.0K | $803.0K | $800.0K | $796.0K | $793.0K | · | |
| Accum. Depreciation | $679.0K | $660.0K | $641.0K | $619.0K | $598.0K | $575.0K | $554.0K | · | |
| Other Non-current Assets | $128.0K | $126.0K | $224.0K | $219.0K | $216.0K | $215.0K | $213.0K | · | |
| Total Assets | $15M | $18M | $26M | $29M | $31M | $37M | $34M | · | |
| Accounts Payable | $790.0K | $646.0K | $363.0K | $304.0K | $266.0K | $358.0K | $295.0K | · | |
| Accrued Liabilities | $1M | $1M | $938.0K | $990.0K | $926.0K | $909.0K | $840.0K | · | |
| Current Liabilities | $14M | $12M | $14M | $13M | $12M | $13M | $11M | · | |
| Capital Leases | · | · | $0 | $93.0K | $170.0K | $246.0K | $307.0K | · | |
| Other Non-current Liabilities | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | |
| Total Liabilities | $51M | $49M | $50M | $49M | $49M | $50M | $49M | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | $376M | $376M | $376M | $374M | $374M | $373M | $373M | · | |
| Retained Earnings | $-411M | $-411M | $-408M | $-406M | $-405M | $-403M | $-407M | · | |
| AOCI | $55.0K | $360.0K | $602.0K | $913.0K | $1M | $1M | $1M | · | |
| Stockholders' Equity | $-36M | $-34M | $-32M | $-32M | $-30M | $-28M | $-33M | · | |
| Liabilities + Equity | $15M | $18M | $26M | $29M | $31M | $37M | $34M | · | |
| Shares Outstanding | 41,119,820 | 41,119,820 | · | 40,322,320 | 40,322,320 | 40,316,320 | 40,316,320 | · |
Cash Flow 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $575.0K | $461.0K | $167.0K | $166.0K | $145.0K | $244.0K | $399.0K | $827.0K | |
| Operating Cash Flow | $-4M | $-3M | $-6M | $-4M | $-6M | $-4M | $982.0K | $-5M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $50.0K | $27.0K | $197.0K | |
| Investing Cash Flow | $-5.0K | $4M | $-5M | $-1M | $11M | $6M | $-10M | $-2M | |
| Stock Issued | · | · | $2M | $0 | · | · | $0 | $0 | |
| Financing Cash Flow | $-74.0K | $-4M | $2M | $3M | $0 | $0 | $2M | $22M | |
| Net Change in Cash | $-4M | $-3M | $-9M | $-2M | $5M | $2M | $-7M | $15M | |
| Taxes Paid | $0 | $0 | $1.0K | $0 | $1.0K | $0 | $0 | $0 | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · |
Profitability 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -3.7% | -7.8% | · | -10.4% | -11.6% | 24.1% | · | · | |
| ROE | 2.6% | 6.9% | · | 9.7% | 11.9% | -31.6% | · | · | |
| ROIC | 5.2% | 7.0% | · | 5.7% | 6.5% | 9.3% | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 1.1 | · | 1.9 | 2.2 | 2.5 | · | · | |
| Quick Ratio | 0.5 | 0.6 | · | 1.0 | 0.8 | 0.7 | · | · |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · |
Valuation (TTM) 6
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | · | |
| Net Income TTM | $-6M | $-1M | · | $-1M | $-3M | $-5M | · | · | |
| Market Cap | $72M | $67M | · | $73M | $95M | $58M | · | · | |
| P/B | -2.0 | -2.0 | · | -2.3 | -3.1 | -2.0 | · | · | |
| P / Cash Flow | · | -20.6 | · | · | · | -13.8 | · | · | |
| P / FCF | · | -20.6 | · | · | · | -13.6 | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Net Income | $-1M | $-11M | $-21M |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Current Ratio | 1.5 | 2.6 | — |
| Quick Ratio | 0.9 | 0.3 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Free Cash Flow | $-20M | $-17M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 26 filers · $9.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (+6 vs prior Q) | 1 (-7 vs prior Q) | 3 (-1 vs prior Q) | 4 (+2 vs prior Q) | +790K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Decheng Capital LLC | $6,651,229 | 3,800,702 | 70.77% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,096,300 | 626,457 | 11.66% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $508,207 | 290,195 | 5.41% | Shares |
| STATE STREET CORP | $404,460 | 231,120 | 4.30% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $317,093 | 181,196 | 3.37% | Shares |
| BlackRock, Inc. | $158,440 | 90,537 | 1.69% | Shares |
| NORTHERN TRUST CORP | $108,542 | 62,024 | 1.15% | Shares |
| CITADEL ADVISORS LLC | $27,825 | 15,900 | 0.30% | Call option |
| Meridian Wealth Management, LLC | $26,250 | 15,000 | 0.28% | Shares |
| JANE STREET GROUP, LLC | $22,400 | 12,800 | 0.24% | Call option |
| Farther Finance Advisors, LLC | $22,353 | 12,773 | 0.24% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $19,075 | 10,900 | 0.20% | Shares |
| Vanguard Global Advisers, LLC | $8,404 | 4,802 | 0.09% | Shares |
| VANGUARD GROUP INC | $7,827 | 4,802 | 0.08% | Shares |
| MORGAN STANLEY | $7,000 | 4,000 | 0.07% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $5,031 | 2,875 | 0.05% | Shares |
| Trifecta Capital Advisors, LLC | $2,625 | 1,500 | 0.03% | Shares |
| Tower Research Capital LLC (TRC) | $2,566 | 1,466 | 0.03% | Shares |
| SIMPLEX TRADING, LLC | $2,038 | 1,165 | 0.02% | Shares |
| JPMORGAN CHASE & CO | $571 | 319 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $133 | 76 | 0.00% | Shares |
| UBS Group AG | $100 | 57 | 0.00% | Shares |
| TANAKA CAPITAL MANAGEMENT INC | $43 | 26,296 | 0.00% | Shares |
| BARCLAYS PLC | $33 | 19 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $16 | 9 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $2 | 1 | 0.00% | Shares |
Company insiders 8 insiders · 3 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Min Qiu | Chief Executive Officer | July 1, 2026 A | — | 0 | 0 | $0 |
| Lan Huang | Chief Executive Officer | March 20, 2026 G | 0 | 0 | 0 | $0 |
| Yingjuan June Lu | Chief Scientific Officer | April 1, 2026 A | — | 0 | 0 | $0 |
| Jiangwen Majeti | Director | July 1, 2026 A | — | 0 | 0 | $0 |
| Sihai Xu | Director | April 1, 2026 A | — | 0 | 0 | $0 |
| Matthew Kirkby | Director | April 1, 2026 A | — | 0 | 0 | $0 |
| Brendan Delaney | Director | April 1, 2026 A | — | 0 | 0 | $0 |
| Patrick Fabbio | Director | April 1, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Xiangmin Cui ×2 filings | Dec. 8, 2020 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.